A/Prof Sarah Shigdar

Being able to enter the brain non-disruptively to specifically target certain populations of cells is the next step in delivering better QoL to patients #aptamers @OTSociety @JAptamers @AptamerSociety Made even better by separate validation in this study pubs.acs.org/doi/10.1021/ja…

If you're attending in person for next week's conference, please remember to use #AptOx23 and tag @AptamerSociety in your tweets.

We're asking for EOIs for an APAC Aptamers conference in November. If you're interested in attending, please fill out this EOI aus01.safelinks.protection.outlook.com/?url=https%3A%…

And let me know if you want other region specific groups added

We now have a Australia and New Zealand aptamer group on LinkedIn so if you are currently working down under with aptamers, please join. If we get enough members, we may look at some activities here @AptamerSociety linkedin.com/groups/1415144…

Anybody out in the Twitterverse using, prescribing or developing cancer therapeutics that wants to have a quick chat about what they'd like to see in a new drug? @cogno_trials @AptamerSociety

A good article by a non-aptamer specialist who was blown away by my talk at a recent conference #aptamers @JAptamers @AptamerSociety labonline.com.au/content/life-s…

@DavePorciani Thanks Dave! I can't take any of the credit as it was all @Dr_MNakhjavani organisational abilities that put it all together

@aptamer_connect Very nice! I thought of doing something similar for yrs but didn’t have enough bandwidth to do it.. I’m glad something similar is out now!

We did a JoVE. Paper is out and leads you through how to use aptamers in immunophenotyping assays instead of antibodies. Video coming soon. jove.com/t/64304

Off to buy a lotto ticket after satisfying Reviewer #2 in the first round on a paper! More info to come soon but kind of builds on the work we've done with our bifunctional aptamers :) liebertpub.com/doi/full/10.10…

The lastest edition of INSOAP Times is out if you want so see what's happening with aptamers at the moment @AptamerSociety @JAptamers @mmckeague @MalikaratchyLab aptamersociety.org/business/insoa…

@AptamerSociety @juliantanner1 @Sanskritihiya There are a number of adaptations to the SELEX process that may speed it up, depending on what your target is

@aptamer_connect @juliantanner1: For de-novo production of aptamers for biomarkers, is there any alternative other than SELEX? Since it takes a lot of time to find one using SELEX. Can someone help on this?. Any lead would be appreciated. @Sanskritihiya

Looking forward to next year's conference. Save the date!#OzNanomed I'm encouraged that #aptamers were mentioned every day 😊

A special thank you to Kimberly who ensures we all get looked after at #OzNanomed

Excited to present in person at #oznanomed this afternoon on how we get the brain to take its medicine for targeted cancer therapy

Very excited to present at this online European conference to share how #aptamers can cross the blood brain barrier. There's still time to register etkinlik.marmara.edu.tr/ambcongress22

Given the recent article on 'A golden age for cancer research' in Nature on antibody drug conjugates, it's timely to repost this #aptamer @deakinresearch @OTSociety @sciam @NatureMedicine liebertpub.com/doi/full/10.10…

This is an absolutely fantastic application of aptamers. A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk science.org/doi/10.1126/sc… @AptamerSociety

The hybrid Aptamer Symposium has been fantastic with great applications presented. The keynote from Larry Gold is going to be the topic of future lectures. Missed it? We will be writing it up in the newsletter and conference proceedings paper #AptaOx22 @AptamerSociety

The last speaker of #AptaOx22 is Vipasha Sharma talking about Rationally Truncated high affinity Aptamer based Electrochemical Detection of Stress Hormone on Graphene Quantum Dots Modified Screen Printed Electrodes @AptamerSociety

The penultimate talk of the conference is Auriane Guitton-Auberty discussing aptamer-target crosslinks formation #AptaOx22 @AptamerSociety